Infecciones bacterianas en cirrosis: desafíos y perspectivas

Gómez-Ayala, 2012, Cirrosis hepática. Actualización, Farmacia Profesional., 26, 45 Blachier, 2013, The burden of liver disease in Europe: A review of available epidemiological data, J Hepatol., 58, 593, 10.1016/j.jhep.2012.12.005 Asrani, 2013, Underestimation of liver-related mortality in the United States, Gastroenterology., 145, 375, 10.1053/j.gastro.2013.04.005 Dionigi, 2017, Bacterial infections change natural history of cirrhosis irrespective of liver disease severity, Am J Gastroenterol., 112, 588, 10.1038/ajg.2017.19 Jalan, 2014, Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013, J Hepatol., 60, 1310, 10.1016/j.jhep.2014.01.024 Pande, 2009, Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease, Aliment Pharmacol Ther., 29, 1273, 10.1111/j.1365-2036.2009.03994.x Appenrodt, 2010, Nucleotide-binding oligomerization domain containing2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis, Hepatology., 51, 1327, 10.1002/hep.23440 Arvaniti, 2010, Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis, Gastroenterology., 139, 1246, 10.1053/j.gastro.2010.06.019 Fernández, 2012, Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study, Hepatology., 55, 1551, 10.1002/hep.25532 Luyt, 2014, Antibiotic stewardship in the intensive care unit, Critical Care., 18, 480, 10.1186/s13054-014-0480-6 Aithal, 2021, Guidelines on the management of ascites in cirrhosis, Gut., 70, 9, 10.1136/gutjnl-2020-321790 Foreman, 2003, Cirrhosis as a risk factor for sepsis and death: Analysis of the National Hospital Discharge Survey, Chest., 124, 1016, 10.1378/chest.124.3.1016 Fagiuoli, 2014, Management of infections in cirrhotic patients: Report of a consensus conference, Dig Liv Dis., 46, 204, 10.1016/j.dld.2013.07.015 Piano, 2012, Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: The last therapeutic challenge, Eur J Gastroenterol Hepatol., 24, 1234, 10.1097/MEG.0b013e328355d8a2 Bone, 1992, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Chest., 101, 1644, 10.1378/chest.101.6.1644 Zipprich, 2012, Prognostic indicators of survival in patients with compensated and decompensated cirrhosis, Liver Int., 32, 1407, 10.1111/j.1478-3231.2012.02830.x Gustot, 2017, Sepsis in alcohol-related liver disease, J Hepatol., 67, 1031, 10.1016/j.jhep.2017.06.013 Albillos, 2014, Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance, J Hepatol., 61, 1385, 10.1016/j.jhep.2014.08.010 Wasmuth, 2005, Patients with acute on chronic liver failure display «sepsis-like» immune paralysis, J Hepatol., 42, 195, 10.1016/j.jhep.2004.10.019 Wiest, 2014, Pathological bacterial translocation in liver cirrhosis, J Hepatol., 60, 197, 10.1016/j.jhep.2013.07.044 Fernández, 2012, Management of bacterial infections in cirrhosis, J Hepatol., 56, S1, 10.1016/S0168-8278(12)60002-6 Bhattacharya, 2013, Early diagnosis of resistant pathogens: How can it improve antimicrobial treatment?, Virulence., 4, 172, 10.4161/viru.23326 Le Moine, 1995, Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholic cirrhosis, Hepatology., 22, 1436, 10.1002/hep.1840220516 Kim, 2011, Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage, J Gastroenterol Hepatol., 26, 550, 10.1111/j.1440-1746.2010.06490.x Lee, 2017, Bacterial infections in acute variceal hemorrhage despite antibiotics — a multicenter study of predictors and clinical impact, United European Gastroenterol J., 5, 1090, 10.1177/2050640617704564 Cervoni, 2012, C-reactive protein predicts short-term mortality in patients with cirrhosis, J Hepatol., 56, 1299, 10.1016/j.jhep.2011.12.030 Gundling, 2011, Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis, Liver Int., 31, 1406, 10.1111/j.1478-3231.2011.02577.x Pelletier, 1993, Is D-lactate assay useful for the diagnosis of ascitic infection in patients with liver cirrhosis?, Gastroenterol Clin Biol., 17, 304 Tas, 2012, Serum lactate level predict mortality in elderly patients with cirrhosis, Wiener klinische Wochenschrift., 124, 520, 10.1007/s00508-012-0208-z Berres, 2009, Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis, Liver Int., 29, 536, 10.1111/j.1478-3231.2008.01870.x Appenrodt, 2010, Is detection of bacterial DNA in ascitic fluid of clinical relevance?, Eur J Gastroenterol Hepatol., 22, 1487, 10.1097/MEG.0b013e328340c43a Gabay, 1999, Acute-phase proteins and other systemic responses to inflammation, N Engl J Med., 340, 448, 10.1056/NEJM199902113400607 Bota, 2005, Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver, J Lab Clin Med., 146, 347, 10.1016/j.lab.2005.08.005 Park, 2005, Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis, Diagn Microbiol Infect Dis., 51, 227, 10.1016/j.diagmicrobio.2004.11.014 Tsiakalos, 2009, Acute-phase proteins as indicators of bacterial infection in patients with cirrhosis, Liver Int., 29, 1538, 10.1111/j.1478-3231.2009.02088.x Papp, 2012, Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections, Liver Int., 32, 603, 10.1111/j.1478-3231.2011.02689.x Li, 2011, Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department, Acad Emerg Med., 18, 121 Schuetz, 2011, Procalcitonin for diagnosis of infection and guide to antibiotic decisions: Past, present and future, BMC Med., 9, 107, 10.1186/1741-7015-9-107 Wiest, 2012, Spontaneous bacterial peritonitis: Recent guidelines and beyond, Gut., 61, 297, 10.1136/gutjnl-2011-300779 Sort, 1999, Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis, N Eng J Med., 341, 403, 10.1056/NEJM199908053410603 Piano, 2016, The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial, Hepatology., 63, 1299, 10.1002/hep.27941 Reuken, 2013, Mortality after urinary tract infections in patients with advanced cirrhosis. Relevance of acute injury and comorbidities, Liver Int., 33, 220, 10.1111/liv.12029 Nicolle, 2019, Clinical practice guidelines for the management of asymptomatic bacteriuria: 2019 update by Infectious Disease Society of America, Clin Infect Dis., 68, e83, 10.1093/cid/ciz021 Xiol, 1998, Hepatic hydrothorax, Curr Opin Pulm Med., 4, 239, 10.1097/00063198-199807000-00011 Liu, 2008, Risk factors for the outcome of cirrhotic patients with soft tissue infections, J Clin Gastroenterol., 42, 312, 10.1097/MCG.0b013e31802dbde8 Hamza, 2014, Risk factor of cellulitis in cirrhosis and antibiotic prophylaxis in preventing recurrence, Ann Gastroenterol., 27, 374 De Franchis, 2010, Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol., 53, 762, 10.1016/j.jhep.2010.06.004 Tandon, 2015, Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics, Clin Gastroenterol Hepatol., 13, 1189, 10.1016/j.cgh.2014.11.019 Ginés, 1990, Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial, Hepatology., 12, 716, 10.1002/hep.1840120416